Quarterly Consolidated Statement Of Cash Flows

Daito Pharmaceutical Co., Ltd. - Filing #7716453

Concept 2018-06-01 to
2018-11-30
As at
2018-11-30
As at
2018-05-31
As at
2017-11-30
2017-06-01 to
2017-11-30
As at
2017-05-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
2,583,340,000 JPY
2,511,413,000 JPY
Interest and dividends received
39,821,000 JPY
40,716,000 JPY
Interest paid
-10,715,000 JPY
-13,972,000 JPY
Income taxes paid
-683,483,000 JPY
-963,606,000 JPY
Net cash provided by (used in) operating activities
1,977,938,000 JPY
1,613,239,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,725,389,000 JPY
-1,984,829,000 JPY
Other, net
18,178,000 JPY
-15,552,000 JPY
Net cash provided by (used in) investing activities
-1,712,171,000 JPY
-2,004,371,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
600,000,000 JPY
1,100,000,000 JPY
Repayments of long-term borrowings
-1,046,202,000 JPY
-1,134,797,000 JPY
Purchase of treasury shares
-183,000 JPY
-493,000 JPY
Dividends paid
-225,016,000 JPY
-223,327,000 JPY
Net cash provided by (used in) financing activities
-195,972,000 JPY
472,198,000 JPY
Effect of exchange rate change on cash and cash equivalents
-11,457,000 JPY
12,917,000 JPY
Net increase (decrease) in cash and cash equivalents
58,336,000 JPY
93,983,000 JPY
Cash and cash equivalents
1,769,786,000 JPY
1,711,449,000 JPY
1,711,320,000 JPY
1,617,337,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.